Bardy Diagnostics is a company manufacturing an ambulatory cardiac patch for remote monitoring. It develops Carnation Ambulatory Monitor (CAM). The Company's product monitors patients' cardiac activity and detects arrhythmia over a seven-day period.
|Employees (est.) (Sep 2019)||78||(+4%)|
Bardy Diagnostics total Funding
Bardy Diagnostics latest funding size
Time since last funding
|5 months ago|
Bardy Diagnostics investors
|Health Enterprise Partners, Square 1 Bank, River Cities Capital Funds, SV Life Sciences, Ascension Ventures, Aperture Venture Partners, Aphelion Capital, Rex Health Ventures, HealthQuest Capital, SV Health Investors, Lumira Ventures|
Bardy Diagnostics has 1.27k Twitter Followers. The number of followers has increased 0.6% quarter over quarter
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
When was Bardy Diagnostics founded?
Bardy Diagnostics was founded in 2013.
Who are Bardy Diagnostics key executives?
Bardy Diagnostics's key executives are Gust H. Bardy, Mark Handfelt and Mark Querry.
How many employees does Bardy Diagnostics have?
Bardy Diagnostics has 78 employees.
Who are Bardy Diagnostics competitors?
Competitors of Bardy Diagnostics include RSP Systems, Cogentix Medical and CellAegis Devices.
Where is Bardy Diagnostics headquarters?
Bardy Diagnostics headquarters is located at 200 Providence Rd #104, Charlotte.
Where are Bardy Diagnostics offices?
Bardy Diagnostics has an office in Charlotte.
How many offices does Bardy Diagnostics have?
Bardy Diagnostics has 1 office.
Receive alerts for 300+ data fields across thousands of companies